HBW Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
8,688
-401
-4% -$10.5K 0.02% 444
2026
Q1
$255K Buy
9,089
+292
+3% +$7.77K 0.03% 381
2025
Q4
$219K Buy
+8,797
New +$222K 0.02% 391
2025
Q3
Sell
-8,712
Closed -$211K 441
2025
Q2
$211K Buy
+8,712
New +$203K 0.03% 382
2024
Q4
Sell
-10,542
Closed -$305K 400
2024
Q3
$305K Buy
10,542
+258
+3% +$7.53K 0.04% 275
2024
Q2
$288K Buy
10,284
+2,893
+39% +$79.6K 0.05% 264
2024
Q1
$213K Hold
7,391
0.04% 282
2023
Q4
$213K Sell
7,391
-8,478
-53% -$256K 0.04% 282
2023
Q3
$526K Sell
15,869
-532
-3% -$18.8K 0.11% 171
2023
Q2
$602K Buy
16,401
+1,795
+12% +$69.9K 0.13% 164
2023
Q1
$596K Sell
14,606
-832
-5% -$35.9K 0.15% 154
2022
Q4
$791K Buy
15,438
+190
+1% +$9.11K 0.21% 123
2022
Q3
$668K Buy
15,248
+3,851
+34% +$187K 0.19% 139
2022
Q2
$598K Sell
11,397
-2,017
-15% -$103K 0.15% 137
2022
Q1
$694K Sell
13,414
-5,705
-30% -$296K 0.24% 107
2021
Q4
$1.13M Buy
19,119
+640
+3% +$31.7K 0.26% 93
2021
Q3
$794K Buy
18,479
+1,879
+11% +$83.2K 0.21% 121
2021
Q2
$650K Buy
16,600
+5,918
+55% +$230K 0.17% 130
2021
Q1
$387K Buy
10,682
+4,030
+61% +$143K 0.1% 164
2020
Q4
$245K Buy
6,652
+261
+4% +$9.57K 0.07% 190
2020
Q3
$223K Buy
+6,391
New +$224K 0.09% 172

Other funds holding PFE

HBW Advisory Services's PFE Position: Q2 2026 in Review

HBW Advisory Services reduced its Pfizer (PFE) stake by 4.4% in Q2 2026, selling an estimated $10.5K and leaving 8,688 shares worth $209K. The position accounts for 0.02% of the portfolio, ranked #444.

HBW Advisory Services first reported a position in PFE in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.13M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • HBW Advisory Services held 8,688 shares of Pfizer worth $209K as of Q2 2026.
  • HBW Advisory Services sold 401 Pfizer shares in Q2 2026, an estimated $10.5K.
  • Pfizer made up 0.02% of HBW Advisory Services's portfolio in Q2 2026, its #444 holding.
  • HBW Advisory Services first reported a position in Pfizer in Q3 2020 and has held it in 21 quarters since.
  • HBW Advisory Services's Pfizer position peaked at $1.13M in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.